{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:55:04Z","timestamp":1790686504423,"version":"4.1.0"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science and Technology Key Project of Henan Province","award":["262102311136"],"award-info":[{"award-number":["262102311136"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_med-2026-1542_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>MASLD has a prevalence of almost one-third in adults worldwide and is not currently treated pharmacologically with a first-line therapy. Lifestyle change is still the foundation of management; however, the relative effectiveness of behavioral and dietary approaches remains uncertain. We compared behavioral motivation support (BMS), biomarker-guided personalized dietary management (BPDM), general dietary education (GDE), and prescribed dietary models (PDM) with usual care (UC) in adults with MASLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1542_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eight databases and two trial registers were searched from inception to 31 March 2026. The review record was first submitted to PROSPERO on 17 April 2026 and formally registered on 18 April 2026 (CRD420261371973), after the search but before data extraction. Random-effects frequentist NMA was used where networks were sufficiently connected; outcomes measured with different instruments were analyzed using Hedges\u2019 g or narratively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1542_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fourteen RCTs (n=1,805) were included. Compared with UC, BMS was associated with lower ALT (MD\u00a0\u22127.41\u202fU\/L, 95\u202f% CI\u00a0\u221211.07 to\u00a0\u22123.76) and BMI (MD\u00a0\u22121.34\u202fkg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , 95\u202f% CI\u00a0\u22122.31 to\u00a0\u22120.37), while BPDM was associated with lower ALT (MD\u00a0\u22126.72\u202fU\/L, 95\u202f% CI\u00a0\u221211.76 to\u00a0\u22121.68), BMI (MD\u00a0\u22121.82\u202fkg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , 95\u202f% CI\u00a0\u22123.15 to\u00a0\u22120.50), and body weight (MD\u00a0\u22126.66\u202fkg, 95\u202f% CI\u00a0\u22128.47 to\u00a0\u22124.86). The HbA1c network was sparse and did not include BMS. Nutrition behavior was analyzed as an exploratory two-study pairwise meta-analysis (Hedges\u2019 g 1.64, 95\u202f% CI\u00a0\u22120.25 to 3.52), and self-efficacy was synthesized narratively. CINeMA confidence was very low across all 88 assessed network comparisons.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1542_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings are hypothesis-generating and do not establish superiority, complementary clinical roles, or treatment recommendations. Direct comparative trials are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2026-1542","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:58:44Z","timestamp":1790683124000},"source":"Crossref","is-referenced-by-count":0,"title":["Behavioral motivation support versus personalized dietary management for metabolic and behavioral outcomes in MASLD: a network meta-analysis"],"prefix":"10.1515","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8560-8532","authenticated-orcid":false,"given":"Chao","family":"Wang","sequence":"first","affiliation":[{"name":"School of Nursing , Henan University of Science and Technology , Luoyang , Henan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5665-1530","authenticated-orcid":false,"given":"Ziying","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Nursing , Henan University of Science and Technology , Luoyang , Henan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0363-4418","authenticated-orcid":false,"given":"Pan","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Nursing , Henan University of Science and Technology , Luoyang , Henan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5032-2727","authenticated-orcid":false,"given":"Niuniu","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Nursing , Henan University of Science and Technology , Luoyang , Henan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2664-9891","authenticated-orcid":false,"given":"Lanhong","family":"Ruan","sequence":"additional","affiliation":[{"name":"School of Nursing , Henan University of Science and Technology , Luoyang , Henan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9392-8970","authenticated-orcid":false,"given":"Mengyuan","family":"Qiao","sequence":"additional","affiliation":[{"name":"School of Nursing , Henan University of Science and Technology , Luoyang , Henan Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"2026092911583252696_j_med-2026-1542_ref_001","doi-asserted-by":"crossref","unstructured":"Rinella, ME, Lazarus, JV, Ratziu, V, Francque, SM, Sanyal, AJ, Kanwal, F, et al.. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatol Baltim Md 2023;78:1966\u201386. https:\/\/doi.org\/10.1097\/HEP.0000000000000520.","DOI":"10.1097\/HEP.0000000000000520"},{"key":"2026092911583252696_j_med-2026-1542_ref_002","doi-asserted-by":"crossref","unstructured":"Younossi, ZM, Golabi, P, Paik, JM, Henry, A, Van Dongen, C, Henry, L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatol Baltim Md 2023;77:1335\u201347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004.","DOI":"10.1097\/HEP.0000000000000004"},{"key":"2026092911583252696_j_med-2026-1542_ref_003","doi-asserted-by":"crossref","unstructured":"Tilg, H, Petta, S, Stefan, N, Targher, G. Metabolic dysfunction-associated steatotic liver disease in adults: a review. JAMA 2026;335:163\u201374. https:\/\/doi.org\/10.1001\/jama.2025.19615.","DOI":"10.1001\/jama.2025.19615"},{"key":"2026092911583252696_j_med-2026-1542_ref_004","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J\u00a0Hepatol 2024;81:492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031.","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"2026092911583252696_j_med-2026-1542_ref_005","doi-asserted-by":"crossref","unstructured":"Houttu, V, Csader, S, Nieuwdorp, M, Holleboom, AG, Schwab, U. Dietary interventions in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Nutr 2021;8:716783. https:\/\/doi.org\/10.3389\/fnut.2021.716783.","DOI":"10.3389\/fnut.2021.716783"},{"key":"2026092911583252696_j_med-2026-1542_ref_006","doi-asserted-by":"crossref","unstructured":"Page, MJ, McKenzie, JE, Bossuyt, PM, Boutron, I, Hoffmann, TC, Mulrow, CD, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"2026092911583252696_j_med-2026-1542_ref_007","doi-asserted-by":"crossref","unstructured":"Hutton, B, Salanti, G, Caldwell, DM, Chaimani, A, Schmid, CH, Cameron, C, et al.. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 2015;162:777\u201384. https:\/\/doi.org\/10.7326\/M14-2385.","DOI":"10.7326\/M14-2385"},{"key":"2026092911583252696_j_med-2026-1542_ref_009","doi-asserted-by":"crossref","unstructured":"Nourian, M, Askari, G, Golshiri, P, Miraghajani, M, Shokri, S, Arab, A. Effect of lifestyle modification education based on health belief model in overweight\/obese patients with non-alcoholic fatty liver disease: a parallel randomized controlled clinical trial. Clin Nutr ESPEN 2020;38:236\u201341. https:\/\/doi.org\/10.1016\/j.clnesp.2020.04.004.","DOI":"10.1016\/j.clnesp.2020.04.004"},{"key":"2026092911583252696_j_med-2026-1542_ref_010","doi-asserted-by":"crossref","unstructured":"Li, L, Hou, K, Yuan, M, Zhang, Y, Zhang, Y. Change lifestyle modification plan\/transtheoretical model in non-alcoholic simple fatty liver disease: a pilot randomized study. BMC Gastroenterol 2022;22:483. https:\/\/doi.org\/10.1186\/s12876-022-02506-4.","DOI":"10.1186\/s12876-022-02506-4"},{"key":"2026092911583252696_j_med-2026-1542_ref_011","doi-asserted-by":"crossref","unstructured":"Mobasheri, N, Ghahremani, L, Fallahzadeh Abarghooee, E, Hassanzadeh, J. Lifestyle intervention for patients with nonalcoholic fatty liver disease: a randomized clinical trial based on the theory of planned behavior. BioMed Res Int 2022;2022:3465980. https:\/\/doi.org\/10.1155\/2022\/3465980.","DOI":"10.1155\/2022\/3465980"},{"key":"2026092911583252696_j_med-2026-1542_ref_012","doi-asserted-by":"crossref","unstructured":"Axley, P, Kodali, S, Kuo, Y-F, Ravi, S, Seay, T, Parikh, NM, et al.. Text messaging approach improves weight loss in patients with nonalcoholic fatty liver disease: a randomized study. Liver Int Off J Int Assoc Study Liver 2018;38:924\u201331. https:\/\/doi.org\/10.1111\/liv.13622.","DOI":"10.1111\/liv.13622"},{"key":"2026092911583252696_j_med-2026-1542_ref_013","doi-asserted-by":"crossref","unstructured":"Stine, JG, Rivas, G, Hummer, B, Duarte-Rojo, A, May, CN, Geyer, N, et al.. Mobile health lifestyle intervention program leads to clinically significant loss of body weight in patients with NASH. Hepatol Commun 2023;7:e0052. https:\/\/doi.org\/10.1097\/HC9.0000000000000052.","DOI":"10.1097\/HC9.0000000000000052"},{"key":"2026092911583252696_j_med-2026-1542_ref_015","doi-asserted-by":"crossref","unstructured":"Huang, X, Luo, M, Zeng, Y, Yi, J, Lin, S, Wang, Y, et al.. Effect of therapeutic lifestyle changes on patients with overweight\/obesity and non-alcoholic fatty liver disease: a randomized controlled trial. Am J Med Sci 2025;369:373\u20139. https:\/\/doi.org\/10.1016\/j.amjms.2024.10.005.","DOI":"10.1016\/j.amjms.2024.10.005"},{"key":"2026092911583252696_j_med-2026-1542_ref_016","doi-asserted-by":"crossref","unstructured":"Dong, F, Zhang, Y, Huang, Y, Wang, Y, Zhang, G, Hu, X, et al.. Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. Sci Rep 2016;6:36783. https:\/\/doi.org\/10.1038\/srep36783.","DOI":"10.1038\/srep36783"},{"key":"2026092911583252696_j_med-2026-1542_ref_017","doi-asserted-by":"crossref","unstructured":"Cai, H-J, Liang, H-L, Shi, L-Y, Rong, Y-H, Li, J, Zhang, Y, et al.. Enhancing MAFLD care: efficacy of a multidisciplinary community intervention on self-management and hepatic outcomes. Inq J Med Care Organ Provis Financ 2025;62:469580251380071. https:\/\/doi.org\/10.1177\/00469580251380071.","DOI":"10.1177\/00469580251380071"},{"key":"2026092911583252696_j_med-2026-1542_ref_021","doi-asserted-by":"crossref","unstructured":"Kwon, OY, Lee, MK, Lee, HW, Kim, H, Lee, JS, Jang, Y. Mobile app-based lifestyle coaching intervention for patients with nonalcoholic fatty liver disease: randomized controlled trial. J\u00a0Med Internet Res 2024;26:e49839. https:\/\/doi.org\/10.2196\/49839.","DOI":"10.2196\/49839"},{"key":"2026092911583252696_j_med-2026-1542_ref_014","doi-asserted-by":"crossref","unstructured":"Sun, C, Chen, G, Shi, C, Cao, H, Yang, R, Zeng, J, et al.. Therapeutic effects of a WeChat mini-program on metabolic dysfunction-associated fatty liver disease: randomized controlled trial. J\u00a0Med Internet Res 2026;28:e76204. https:\/\/doi.org\/10.2196\/76204.","DOI":"10.2196\/76204"},{"key":"2026092911583252696_j_med-2026-1542_ref_018","doi-asserted-by":"crossref","unstructured":"Liu, Z, Jin, P, Liu, Y, Zhang, Z, Wu, X, Weng, M, et al.. A comprehensive approach to lifestyle intervention based on a calorie-restricted diet\u00a0ameliorates liver fat in overweight\/obese patients with NAFLD: a multicenter randomized controlled trial in China. Nutr J 2024;23:64. https:\/\/doi.org\/10.1186\/s12937-024-00968-8.","DOI":"10.1186\/s12937-024-00968-8"},{"key":"2026092911583252696_j_med-2026-1542_ref_019","doi-asserted-by":"crossref","unstructured":"Joshi, S, Shamanna, P, Dharmalingam, M, Vadavi, A, Keshavamurthy, A, Shah, L, et al.. Digital twin-enabled personalized nutrition improves metabolic dysfunction-associated fatty liver disease in type 2 diabetes: results of a 1-Year randomized controlled study. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 2023;29:960\u201370. https:\/\/doi.org\/10.1016\/j.eprac.2023.08.016.","DOI":"10.1016\/j.eprac.2023.08.016"},{"key":"2026092911583252696_j_med-2026-1542_ref_020","doi-asserted-by":"crossref","unstructured":"Johari, MI, Yusoff, K, Haron, J, Nadarajan, C, Ibrahim, KN, Wong, MS, et al.. A randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease. Sci Rep 2019;9:11232. https:\/\/doi.org\/10.1038\/s41598-019-47763-8.","DOI":"10.1038\/s41598-019-47763-8"},{"key":"2026092911583252696_j_med-2026-1542_ref_022","doi-asserted-by":"crossref","unstructured":"Holmer, M, Lindqvist, C, Petersson, S, Moshtaghi-Svensson, J, Tillander, V, Brismar, TB, et al.. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. JHEP Rep Innov Hepatol 2021;3:100256. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100256.","DOI":"10.1016\/j.jhepr.2021.100256"},{"key":"2026092911583252696_j_med-2026-1542_ref_023","doi-asserted-by":"crossref","unstructured":"Sterne, JAC, Savovi\u0107, J, Page, MJ, Elbers, RG, Blencowe, NS, Boutron, I, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","DOI":"10.1136\/bmj.l4898"},{"key":"2026092911583252696_j_med-2026-1542_ref_024","doi-asserted-by":"crossref","unstructured":"Balduzzi, S, R\u00fccker, G, Nikolakopoulou, A, Papakonstantinou, T, Salanti, G, Efthimiou, O, et al.. Netmeta: an R package for network meta-analysis using frequentist methods. J\u00a0Stat Software 2023;106:1\u201340. https:\/\/doi.org\/10.18637\/jss.v106.i02.","DOI":"10.18637\/jss.v106.i02"},{"key":"2026092911583252696_j_med-2026-1542_ref_008","doi-asserted-by":"crossref","unstructured":"Wan, X, Wang, W, Liu, J, Tong, T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","DOI":"10.1186\/1471-2288-14-135"},{"key":"2026092911583252696_j_med-2026-1542_ref_025","doi-asserted-by":"crossref","unstructured":"Papakonstantinou, T, Nikolakopoulou, A, Higgins, JPT, Egger, M, Salanti, G. CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis. Campbell Syst Rev 2020;16:e1080. https:\/\/doi.org\/10.1002\/cl2.1080.","DOI":"10.1002\/cl2.1080"},{"key":"2026092911583252696_j_med-2026-1542_ref_029","doi-asserted-by":"crossref","unstructured":"Nothwehr, F. Self-efficacy and its association with use of diet-related behavioral strategies and reported dietary intake. Health Educ Behav 2008;35:698\u2013706. https:\/\/doi.org\/10.1177\/1090198106296771.","DOI":"10.1177\/1090198106296771"},{"key":"2026092911583252696_j_med-2026-1542_ref_030","doi-asserted-by":"crossref","unstructured":"Prestwich, A, Kellar, I, Parker, R, MacRae, S, Learmonth, M, Sykes, B, et al.. How can self-efficacy be increased? meta-analysis of dietary interventions. Health Psychol Rev 2014;8:270\u201385. https:\/\/doi.org\/10.1080\/17437199.2013.813729.","DOI":"10.1080\/17437199.2013.813729"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1542\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1542\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:58:56Z","timestamp":1790683136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1542\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,29]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/med-2026-1542"],"URL":"https:\/\/doi.org\/10.1515\/med-2026-1542","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20261542"}}